Endorsement of Compulsory HIV Vaccination Policy Among Populations at High Risk of HIV Exposure (LA VOICES)
Compulsory vaccination is a frequently implemented policy option for ensuring comprehensive vaccine coverage. Ongoing controversies around human papillomavirus vaccine dissemination, and suboptimal coverage, suggest the value of assessing acceptability of compulsory vaccinations—particularly among likely target populations—in advance of their public availability to support evidence-informed interventions. With the first HIV vaccine to demonstrate partial efficacy in a large-scale clinical trial, we examined individual characteristics and attitudes associated with support for compulsory HIV vaccination policy among a diverse, representative sample of adults attending probable HIV vaccine dissemination venues in a large urban county. Participants were recruited using three-stage probability sampling from likely venues for future HIV vaccine dissemination. We used Audio-CASI to administer a 60-min structured questionnaire. Items included endorsement of compulsory HIV vaccination policy, sociodemographic characteristics, injecting drug use, vaccine attitudes and perceived HIV risk. Among 1,225 participants (mean age = 36.8 years; 55.6 % males, 37.6 % non-English speaking Hispanic, 78.8 % heterosexual, 25.7 % injection drug users), almost half (48.2 %) endorsed a compulsory HIV vaccination policy. Non-English speaking Hispanics compared to whites, participants with less than high school education, higher positive vaccine attitude scores and higher perceived HIV risk were significantly more likely, and people who inject drugs significantly less likely to endorse compulsory HIV vaccination. Public health interventions to promote positive vaccine attitudes and accurate perceptions of HIV risk among vulnerable populations, and strategies tailored for people who inject drugs, may build support for compulsory HIV vaccination policy and promote broad HIV vaccine coverage.
KeywordsHIV vaccines Vaccination Policy Vulnerable populations Attitudes
This study was funded by a grant from NIMH (R01 MH069087). In addition, Dr. Newman received partial support by grants from the Canadian Institutes of Health Research (THA-118570) and the Canada Research Chairs program. Dr. Cunningham received partial support by grants from NIMHD (2P20MD000182), NIA (P30-AG021684), and NCRR (UL 1RR033176). Dr. Lee received partial support from NIH grants MH58107 and 5K01MH085503.
- Bearman, P. (2010). Just-so stories: Vaccines, autism, and the single-bullet disorder. Social Science Quarterly, 73, 112–115.Google Scholar
- Centers for Disease Control and Prevention. (1998). Effectiveness of a seventh grade school entry vaccination requirement—statewide and Orange County, Florida, 1997–1998. Morbidity and Mortality Weekly Report, 47, 711–715. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/00054618.htm.
- Centers for Disease Control and Prevention. (1999). Ten great public health achievements—United States, 1900–1999. Morbidity and Mortality Weekly Report, 48, 241–243. Retrieved from www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm.
- Centers for Disease Control and Prevention. (2002a). Unrecognized HIV infection, risk behaviors, and perceptions of risk among young black man who have sex with men—six U.S. cities, 1994—1998. Morbidity and Mortality Weekly Report, 51, 733–736. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5133a1.htm.
- Centers for Disease Control and Prevention. (2002b). Substance abuse treatment and public health: Working together to benefit injection drug users. Retrieved from www.cdc.gov/idu/facts/workingtogetherFin.pdf.
- Centers for Disease Control and Prevention. (2002c). Achievements in public health: Hepatitis B vaccination—United States, 1982–2002. Morbidity and Mortality Weekly Report, 51, 549–552,563. Retrieved from www.cdc.gov/mmwr/preview/mmwrhtml/mm5125a3.htm.
- Centers for Disease Control and Prevention. (2006). Hepatitis B vaccination coverage among adults—United States, 2004. Morbidity and Mortality Weekly Report, 55, 509–511. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5518a3.htm.
- Centers for Disease Control and Prevention. (2012a). Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. HIV Surveillance Supplemental Report, 17, 14–22. Retrieved from http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pdf.
- Centers for Disease Control and Prevention. (2012b). Teen vaccination coverage: 2011 National Immunization Survey (NIS)—Teen. Retrieved from www.cdc.gov/vaccines/who/teens/vaccination-coverage.html.
- Centers for Disease Control and Prevention. (2012c). HIV infection and HIV-associated behaviors among injecting drug users—20 cities, United States, 2009. Morbidity and Mortality Weekly Report, 61, 133–138. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6108a1.htm.
- Chesson, H. W., Gift, T. L., Owusu-Edusei, K., Jr., Tao, G., Johnson, A. P., & Kent, C. K. (2011). A brief review of the estimated economic burden of sexually transmitted diseases in the United States: Inflation-adjusted updates of previously published cost studies. Sexually Transmitted Diseases, 38, 889–891.CrossRefPubMedGoogle Scholar
- Fox, J. (1991). Regression Diagnostics. Newberry Park, CA: Sage.Google Scholar
- Gabriel, T., & Grady, D. (2011). In Republican race, a heated battle over the HPV vaccine. Retrieved from www.nytimes.com/2011/09/14/us/politics/republican-candidates-battle-over-hpv-vaccine.html.
- National Conference of State Legislatures. (2013). HPV vaccine. Retrieved from www.ncsl.org/issues-research/health/hpv-vaccine-state-legislation-and-statues.aspx.
- Workowski, K.A., & Berman, S. (2010). Sexually transmitted diseases treatment guidelines, 2010. Recommendations and Reports, 59, 1–110. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s_cid=rr5912a1_e.